Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
6,640,230
-
Share change
-
+6,639,700
-
Total reported value
-
$96,543,193
-
Put/Call ratio
-
11%
-
Price per share
-
$14.54
-
Number of holders
-
66
-
Value change
-
+$96,536,193
-
Number of buys
-
65
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) as of Q3 2017
As of 30 Sep 2017,
MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,640,230 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, TIAA CREF INVESTMENT MANAGEMENT LLC, FRANKLIN RESOURCES INC, Newtyn Management, LLC, Rubric Capital Management LP, STATE STREET CORP, DEUTSCHE BANK AG\, and NORTHERN TRUST CORP.
This page lists
66
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.